Aims Contemporary adjuvant treatment for early breast cancer is associated with improved
survival but at the cost of increased risk of cardiotoxicity and cardiac dysfunction. We tested …

B-type natriuretic peptide (BNP), a neurohormone synthesized in the cardiac ventricles, is
released as preproBNP and then enzymatically cleaved to the N-terminal-proBNP (NT …

Cardiotoxicity is a relatively frequent and potentially serious side effect of traditional and
targeted cancer therapies. Both general measures and specific pharmacologic …

Background B-type natriuretic peptide is released from the cardiac ventricles in response to
increased wall tension. Methods We conducted a prospective study of 1586 patients who …

Background Brain (B-type) natriuretic peptide is a neurohormone synthesized predominantly
in ventricular myocardium. Although the circulating level of this neurohormone has been …

Background—We sought to determine the degree to which B-type natriuretic peptide (BNP)
adds to clinical judgment in the diagnosis of congestive heart failure (CHF). Methods and …

Background In most patients with stable coronary artery disease, plasma cardiac troponin T
levels are below the limit of detection for the conventional assay. The distribution and …

Background—B-type natriuretic peptide (BNP) is a predictor of short-and medium-term
prognosis across the spectrum of acute coronary syndromes (ACS). The N-terminal fragment …

Background Elevated plasma levels of atrial natriuretic peptide (ANP) and the N-terminal
fragment of the ANP prohormone (N-ANP) are associated with decreased left ventricular …

Background Hyperhomocyst (e) inemia is a risk factor for atherosclerosis and is prevalent in
the elderly. The objective of this study was to determine whether hyperhomocyst (e) inemia …